Difference between revisions of "Profiles"
Jump to navigation
Jump to search
| Line 16: | Line 16: | ||
==See Also== | ==See Also== | ||
*[[How to use QIBA Profiles]] | *[[How to use QIBA Profiles]] | ||
| + | *[[QIBA Profile Template]] may provide additional understanding of the structure, rationale and content of a Profile (turn on Full Markup to see the guidance in the Word comments) | ||
| + | *[[Committees]] lists Biomarker Committees developing profiles which may link to DRAFT documents in progress for the next stage. | ||
| + | *[[Profile Conformance]] describes how sites and products claim conformance to a Profile. | ||
| + | |||
| + | |||
*[[Work Product for Review]] | *[[Work Product for Review]] | ||
| − | |||
| − | |||
| − | |||
Revision as of 03:55, 12 May 2016
Profiles published here have completed one of the QIBA Profile Stages of development and been approved by their Biomarker Committee.
Stage 3: Technically Confirmed
Stage 2: Publicly Reviewed
Stage 1: Public Comment
- DCE-MRI Quantification 2011-12-13 (Public Comment ended Feb 2012)
- CT Volumetry for Advanced Disease 2011-07-08 (Public Comment ended Sept 2011)
See Also
- How to use QIBA Profiles
- QIBA Profile Template may provide additional understanding of the structure, rationale and content of a Profile (turn on Full Markup to see the guidance in the Word comments)
- Committees lists Biomarker Committees developing profiles which may link to DRAFT documents in progress for the next stage.
- Profile Conformance describes how sites and products claim conformance to a Profile.